Tri-Plen 2.5 mg/2.5 mg Tablets.
PDF Leaflet Revision Date: 08 September 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate hypertension.
Dosage (summary)
One tablet daily; max one TRI-PLEN FORTE tablet.
Onset of Action / Duration
Onset: 1-2 hours, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Potassium-sparing diuretics
- Aliskiren-containing products
- Angiotensin-II receptor blockers
Contraindications
- Hypersensitivity to components
- History of angioedema
- Severe renal impairment
Common side effects
- Headache
- Dizziness
- Hypotension
Counselling Points
- Monitor blood pressure regularly.
- Avoid potassium supplements.
- Report any signs of angioedema immediately.
Serious warnings
- Angioedema risk
- Dual blockade of RAAS contraindicated
- Symptomatic hypotension
Important Disclaimer
The Tri-Plen 2.5 mg/2.5 mg Tablets. professional information leaflet below is the property of Sanofi-Aventis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
